GILD Buybacks
38 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–38; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| GILEAD SCIENCES, INC. | 2026-03-31 | Reported repurchase cash | $419M |
| GILEAD SCIENCES, INC. | 2025-12-31 | Reported repurchase cash | $230M |
| GILEAD SCIENCES, INC. | 2025-03-31 | Reported repurchase cash | $730M |
| GILEAD SCIENCES, INC. | 2024-12-31 | Reported repurchase cash | $350M |
| GILEAD SCIENCES, INC. | 2024-03-31 | Reported repurchase cash | $400M |
| GILEAD SCIENCES, INC. | 2023-12-31 | Reported repurchase cash | $150M |
| GILEAD SCIENCES, INC. | 2023-03-31 | Reported repurchase cash | $400M |
| GILEAD SCIENCES, INC. | 2022-12-31 | Reported repurchase cash | $792M |
| GILEAD SCIENCES, INC. | 2022-03-31 | Reported repurchase cash | $352M |
| GILEAD SCIENCES, INC. | 2021-12-31 | Reported repurchase cash | $49M |
| GILEAD SCIENCES, INC. | 2021-03-31 | Reported repurchase cash | $309M |
| GILEAD SCIENCES, INC. | 2020-12-31 | Reported repurchase cash | $0.00 |
| GILEAD SCIENCES, INC. | 2020-03-31 | Reported repurchase cash | $1.33B |
| GILEAD SCIENCES, INC. | 2019-12-31 | Reported repurchase cash | $105M |
| GILEAD SCIENCES, INC. | 2019-03-31 | Reported repurchase cash | $834M |
| GILEAD SCIENCES, INC. | 2018-12-31 | Reported repurchase cash | $962M |
| GILEAD SCIENCES, INC. | 2018-03-31 | Reported repurchase cash | $1.04B |
| GILEAD SCIENCES, INC. | 2017-12-31 | Reported repurchase cash | $106M |
| GILEAD SCIENCES, INC. | 2017-03-31 | Reported repurchase cash | $565M |
| GILEAD SCIENCES, INC. | 2016-12-31 | Reported repurchase cash | $1B |
| GILEAD SCIENCES, INC. | 2016-03-31 | Reported repurchase cash | $8B |
| GILEAD SCIENCES, INC. | 2015-12-31 | Reported repurchase cash | $3.05B |
| GILEAD SCIENCES, INC. | 2015-03-31 | Reported repurchase cash | $3B |
| GILEAD SCIENCES, INC. | 2014-12-31 | Reported repurchase cash | $2B |
| GILEAD SCIENCES, INC. | 2014-09-30 | Reported repurchase cash | $1.7B |
| GILEAD SCIENCES, INC. | 2014-06-30 | Reported repurchase cash | $1.2B |
| GILEAD SCIENCES, INC. | 2014-03-31 | Reported repurchase cash | $450M |
| GILEAD SCIENCES, INC. | 2013-12-31 | Reported repurchase cash | $399.74M |
| GILEAD SCIENCES, INC. | 2013-03-31 | Reported repurchase cash | $82.24M |
| GILEAD SCIENCES, INC. | 2012-12-31 | Reported repurchase cash | $200M |
| GILEAD SCIENCES, INC. | 2012-03-31 | Reported repurchase cash | $20.77M |
| GILEAD SCIENCES, INC. | 2011-12-31 | Reported repurchase cash | $226.3M |
| GILEAD SCIENCES, INC. | 2011-03-31 | Reported repurchase cash | $548.7M |
| GILEAD SCIENCES, INC. | 2010-12-31 | Reported repurchase cash | $615.54M |
| GILEAD SCIENCES, INC. | 2010-03-31 | Reported repurchase cash | $162.52M |
| GILEAD SCIENCES, INC. | 2009-12-31 | Reported repurchase cash | $242M |
| GILEAD SCIENCES, INC. | 2009-03-31 | Reported repurchase cash | $230.07M |
| GILEAD SCIENCES, INC. | 2008-12-31 | Reported repurchase cash | $753.51M |